{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-160339","form_type":"8-K","ticker":"PROK","cik":"0001850270","company_name":"PROKIDNEY CORP.","filed_at":"2024-06-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.820367+00:00","generated_at":"2026-06-01T04:41:51.204688+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"ProKidney prices upsized $130M offering of 53.7M shares at $2.42 per share","bullets":["Total offering of 53,719,009 shares at $2.42/share; net proceeds expected ~$136.7M.","Public offering of 42,744,220 shares; underwriters have 30-day option for 6,411,633 more.","Concurrent direct offering of 11,030,574 shares to certain investors; closings not contingent.","Expected close June 13; proceeds for clinical trials, R&D, pre-commercial activities.","Jefferies, J.P. Morgan, Guggenheim lead underwriting; PJT Partners as co-manager/adviser."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-160339","json":"https://secwatch.observer/filing/0001193125-24-160339.json","markdown":"https://secwatch.observer/filing/0001193125-24-160339.md","text":"https://secwatch.observer/filing/0001193125-24-160339.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1850270/000119312524160339/0001193125-24-160339-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1850270/000119312524160339/d814183d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T04:41:51.204688+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}